Search Results

That’s precisely what Terry’s Corner delivers every week: practical tools from Dr. Terry Kenakin to elevate your science and sharpen your decisions. Premium Members get a 50%+ discount when they join Terry’s Corner. 🚨 First-ever Live AMA with Dr. Kenakin  is happening September 18th, 12- 1 pm EST —exclusively inside Terry’s Corner. Join Terry's Corner Today ➤ Celtarys Research – Confocal Imaging That Preserves GPCR Function Confocal

From Bench Insight to Strategic Advantage Terry Kenakin’s decades of pharmacology leadership converge Kenakin Content trusted by biotech, pharma & academia 💎 $2999/year — one conference cost = a full That’s where Terry’s Corner  changes the game. Monthly AMAs  where you can challenge Terry with your toughest questions. Subscribe to The Kenakin Brief  today ➤

Terry Kenakin will conduct two consecutive courses in September and October 2024.

Kenakin reveals how Schild’s equation became the first real “receptor test”—a filter that separates mechanistic Kenakin emphasizes, “Schild plots don’t just confirm competition—they expose when competition is an illusion In Kenakin's words, “Every slope, every curvature, every failure to fit—those are the whispers of the Watch the course trailer 👇 Why Terry’s Corner Weekly pharmacology lectures by Dr. Terry Kenakin, monthly AMAs, and a growing on-demand library help scientists sharpen fundamentals, challenge

Kenakin dissects how P450s can be both protective and problematic. Terry Kenakin This Month’s Live AMA — October 30 at 12 PM EST Join Dr. Kenakin live for an open Q&A session designed for discovery scientists. Kenakin with your own enzyme or GPCR interaction puzzles. Subscribe to The Kenakin Brief  today ➤

It took data, yes—but also a deep partnership with GPCR legend Terry Kenakin to bridge industry credibility

Terry Kenakin's educational initiative this fall!

Stuart Maudsley, Nicole Perry-Hauser, Lauren Slosky, Cesare Orlandi, and Simone Prömel. Terry Kenakin's "Applying Pharmacology to Drug Discovery" course at Dr.

Terry Kenakin will return for two consecutive courses in September and October 2024.

Terry Kenakin. Kenakin, access to a dedicated group, course materials, recordings, and a completion certificate endorsed Kenakin and Dr. GPCR.

Terry Kenakin. The course covers basic pharmacology in four weekly segments. Kenakin, according to his availability Access to the cohort’s Dr. Kenakin and your classmates Access to the course materials and recordings Course completion certificate Kenakin and Dr. GPCR Complimentary one-year Dr.

Terry Kenakin. The course covers basic pharmacology in four weekly segments. Only ten spots remain. Kenakin, according to his availability Access to the cohort’s Dr. Kenakin and your classmates Access to the course materials and recordings Course completion certificate Kenakin and Dr. GPCR Complimentary one-year Dr.

Terry Kenakin.

Terry Kenakin will lead two brand-new, back-to-back courses tailored for the Dr.

Nicole Perry-Hauser, on her selection as a 2024 Discovery Science Emerging Scholar at Vanderbilt University Terry Kenakin. The course covers basic pharmacology in four weekly segments. Kenakin, according to his availability Access to the cohort’s Dr. Kenakin and your classmates Access to the course materials and recordings once the course is completed Kenakin and Dr. GPCR Access to Dr.

Terry Kenakin will return for two consecutive courses in September and October 2024.

Terry Kenakin, starts February 8th, 2024. Due to popular demand, we have opened additional spots. Kenakin in a small group setting, hurry and register today. Only three spots remain. Kenakin Access to the cohort’s Dr. Kenakin and Dr. GPCR Complimentary one-year Dr.

Terry Kenakin. The course covers basic pharmacology in four weekly segments. Kenakin, according to his availability Access to the cohort’s Dr. Kenakin and your classmates Access to the course materials and recordings once the course is completed Kenakin and Dr. GPCR Access to Dr.

Terry Kenakin's "Applying Pharmacology to Drug Discovery" course at Dr.

Terry Kenakin, Dr. Oliver Hartley, Dr. Pierre Eftekhari, Dr. Lauren Slosky, Dr. Christel Menet, Dr.

Terry Kenakin, was a resounding success; we have a waitlist for those eager to attend this course, which

Terry Kenakin.

Terry Kenakin.

Terry Kenakin. We would like to extend our heartfelt thanks to Dr. Kenakin for his invaluable contributions and to all the participants for their active involvement and Chain Reaction Orphan GPR52 as an emerging neurotherapeutic target Sustained antidepressant effects of ketamine

Terry Kenakin will return for two consecutive courses in September and October 2024.

Terry Kenakin, have been amazing.

Terry Kenakin. Mark your calendars because registration opens on July 18, 2024!

Terry Kenakin will conduct two back-to-back courses this fall.

Terry Kenakin will return with two back-to-back classes.

Terry Kenakin.